Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
4
×
life sciences
national blog main
san francisco blog main
4
×
deals
akouos
cancer
clinical trials
fda
ipo
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco top stories
startups
venture capital
abbvie
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
armo biosciences
astellas pharmaceuticals
astrazeneca
autoimmune
avalon ventures
biogen
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
california institute for biomedical research
cancer diagnostics
cancer immunotherapy
cerovene
coi pharmaceuticals
correlation ventures
What
plans
4
×
ipo
announced
company
developing
medicines
acquisitions
advance
affects
americans
approved
area
based
bay
bio
biology
biopsy
blood
buildout
cancer
ceo
close
collabs
covid
cytokine
daniel
date
deal
drug
drugs
enhanced
fda
files
firm
frequency
genomic
gilead
gilead’s
hearing
help
Language
unset
Current search:
biotech
×
" san francisco blog main "
×
plans
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs